Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-12 Sale |
2022-07-14 5:33 pm |
VistaGen Therapeutics Inc. | VTGN | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
60,000 | $0.89 | $53,400 | 20,637,286 (Indirect) |
View |
| 2021-09-07 Sale |
2021-09-08 6:58 pm |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
30,000 | $3.125 | $93,750 | 72,786 (Direct) |
View |
| 2021-08-17 Purchase |
2021-08-18 6:20 pm |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
3,750 | $2.73 | $10,238 | 94,865 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-30 Option Award |
2022-07-15 4:30 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
5,000 | $0.748 | 19,915 (Direct) |
View |
Ownership |
2022-07-08 4:09 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
0 | $0 | 20,697,286 (Indirect) |
View |
| 2022-05-12 Exercise |
2022-05-16 1:39 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
100,000 | $1 | 245,232 (Direct) |
View |
| 2022-05-12 Exercise |
2022-05-16 1:39 pm |
N/A 2029-09-05 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
100,000 | $0 | 245,232 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-03 5:10 pm |
N/A 2032-05-02 |
VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2022-05-03 5:07 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER |
0 | $0 | 282,129 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:17 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:16 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:15 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:14 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:13 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:13 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:12 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:11 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Rotunno Mary L. Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:10 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-12 5:21 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
18,750 | $1 | 110,196 (Direct) |
View |
| 2022-01-11 Exercise |
2022-01-12 5:21 pm |
N/A 2029-05-23 |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
18,750 | $0 | 110,196 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:25 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
2,655 | $1.6575 | 14,915 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:20 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
3,575 | $1.6575 | 75,821 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:19 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
3,623 | $1.6575 | 98,859 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:17 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
3,623 | $1.6575 | 75,232 (Direct) |
View |
| 2021-08-23 Gift |
2021-09-03 4:19 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
1,851 | $0 | 95,236 (Indirect) |
View |
| 2021-07-21 Option Award |
2021-07-22 4:11 pm |
N/A 2031-07-21 |
VistaGen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-07 4:49 pm |
N/A 2031-07-06 |
VistaGen Therapeutics Inc. | VTGN | Rotunno Mary L. Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:11 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
2,260 | $1.9465 | 12,260 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
3,044 | $1.9465 | 390,630 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
1,000 | $1.5 | 390,630 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
9,824 | $0.398 | 390,630 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
78,918 | $1 | 390,630 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 4:10 pm |
2018-08-29 2023-10-27 |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
89,742 | $0 | 390,630 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $1.9465 | 71,609 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
3,391 | $1.9465 | 91,115 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:39 pm |
N/A 2031-05-01 |
VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $1.5 | 66,609 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0 | 66,609 (Direct) |
View |
| 2021-04-23 Option Award |
2021-04-27 4:10 pm |
N/A 2031-04-23 |
VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:06 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
2,500 | $1.5 | 2,500 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:06 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
2,500 | $0 | 2,500 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:03 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
2,500 | $1.5 | 55,751 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:03 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
2,500 | $0 | 55,751 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 5:17 pm |
N/A 2031-02-01 |
VistaGen Therapeutics Inc. | VTGN | Ginski Mark J SENIOR VP, HEAD OF CMC |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-02-02 5:16 pm |
N/A 2030-09-09 |
VistaGen Therapeutics Inc. | VTGN | Ginski Mark J SENIOR VP, HEAD OF CMC |
0 | $0 | 50,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:59 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director |
75,000 | $0 | 75,000 (Direct) |
View |